Cyriac Roeding is the founder of Earli. Earli has raised $104M in total funding. Backed by Andreessen Horowitz, Khosla Ventures, Perceptive Advisors.
Cyriac Roeding is the CEO and co-founder of Earli, a bio-AI company focused on developing genetic switches for cancer treatment using AI and intravenous injection. He launched Earli and received full clinical trial approval in April 2021, with the first patient dosed in June 2021.
Full founder directory · Investor directory · Company funding database · Fundraising library